Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Invested Capital: 2009-2024

Historic Invested Capital for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $28.0 million.

  • Cumberland Pharmaceuticals' Invested Capital fell 15.11% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year decrease of 15.11%. This contributed to the annual value of $28.0 million for FY2024, which is 5.57% down from last year.
  • Cumberland Pharmaceuticals' Invested Capital amounted to $28.0 million in FY2024, which was down 5.57% from $29.6 million recorded in FY2023.
  • Cumberland Pharmaceuticals' Invested Capital's 5-year high stood at $47.0 million during FY2020, with a 5-year trough of $28.0 million in FY2024.
  • Moreover, its 3-year median value for Invested Capital was $29.6 million (2023), whereas its average is $31.3 million.
  • Data for Cumberland Pharmaceuticals' Invested Capital shows a maximum YoY fell of 18.37% (in 2023) over the last 5 years.
  • Cumberland Pharmaceuticals' Invested Capital (Yearly) stood at $47.0 million in 2020, then decreased by 8.89% to $42.8 million in 2021, then dropped by 15.29% to $36.3 million in 2022, then fell by 18.37% to $29.6 million in 2023, then decreased by 5.57% to $28.0 million in 2024.